GERRESHEIMER AG (GXI.DE) Fundamental Analysis & Valuation
FRA:GXI • DE000A0LD6E6
Current stock price
21 EUR
+3.3 (+18.64%)
Last:
This GXI.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GXI.DE Profitability Analysis
1.1 Basic Checks
- GXI had positive earnings in the past year.
- In the past year GXI had a positive cash flow from operations.
- In the past 5 years GXI has always been profitable.
- Each year in the past 5 years GXI had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of 0.50%, GXI is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
- With a Return On Equity value of 1.67%, GXI is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
- Looking at the Return On Invested Capital, with a value of 2.79%, GXI is doing worse than 83.33% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for GXI is below the industry average of 9.03%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
- GXI's Profit Margin of 1.04% is on the low side compared to the rest of the industry. GXI is outperformed by 83.33% of its industry peers.
- GXI's Profit Margin has been stable in the last couple of years.
- With a Operating Margin value of 5.99%, GXI is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
- In the last couple of years the Operating Margin of GXI has grown nicely.
- Looking at the Gross Margin, with a value of 26.89%, GXI is doing worse than 72.22% of the companies in the same industry.
- GXI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. GXI.DE Health Analysis
2.1 Basic Checks
- GXI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for GXI remains at a similar level compared to 1 year ago.
- GXI has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for GXI is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.90, we must say that GXI is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of GXI (0.90) is worse than 77.78% of its industry peers.
- A Debt/Equity ratio of 1.22 is on the high side and indicates that GXI has dependencies on debt financing.
- GXI has a Debt to Equity ratio of 1.22. This is in the lower half of the industry: GXI underperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.9 |
ROIC/WACC0.37
WACC7.49%
2.3 Liquidity
- GXI has a Current Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
- GXI has a Current ratio of 0.98. This is in the lower half of the industry: GXI underperforms 72.22% of its industry peers.
- A Quick Ratio of 0.52 indicates that GXI may have some problems paying its short term obligations.
- GXI has a Quick ratio of 0.52. This is in the lower half of the industry: GXI underperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. GXI.DE Growth Analysis
3.1 Past
- GXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.08%.
- Measured over the past years, GXI shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
- GXI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.83%.
- Measured over the past years, GXI shows a small growth in Revenue. The Revenue has been growing by 7.90% on average per year.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
- GXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.46% yearly.
- Based on estimates for the next years, GXI will show a small growth in Revenue. The Revenue will grow by 6.99% on average per year.
EPS Next Y-53.76%
EPS Next 2Y-26.46%
EPS Next 3Y-9.08%
EPS Next 5Y3.46%
Revenue Next Year12.78%
Revenue Next 2Y7.56%
Revenue Next 3Y6.88%
Revenue Next 5Y6.99%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. GXI.DE Valuation Analysis
4.1 Price/Earnings Ratio
- GXI is valuated cheaply with a Price/Earnings ratio of 5.69.
- 100.00% of the companies in the same industry are more expensive than GXI, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of GXI to the average of the S&P500 Index (27.38), we can say GXI is valued rather cheaply.
- The Price/Forward Earnings ratio is 8.30, which indicates a very decent valuation of GXI.
- Based on the Price/Forward Earnings ratio, GXI is valued cheaper than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 38.20, GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.69 | ||
| Fwd PE | 8.3 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GXI is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.64 |
4.3 Compensation for Growth
- A cheap valuation may be justified as GXI's earnings are expected to decrease with -9.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.46%
EPS Next 3Y-9.08%
5. GXI.DE Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.24%, GXI is not a good candidate for dividend investing.
- The stock price of GXI dropped by -30.20% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- GXI's Dividend Yield is slightly below the industry average, which is at 0.52.
- With a Dividend Yield of 0.24, GXI pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
5.2 History
- The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
- 10.12% of the earnings are spent on dividend by GXI. This is a low number and sustainable payout ratio.
- GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP10.12%
EPS Next 2Y-26.46%
EPS Next 3Y-9.08%
GXI.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:GXI (4/16/2026, 5:29:14 PM)
21
+3.3 (+18.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-26 2026-02-26/amc
Earnings (Next)04-16 2026-04-16
Inst Owners93%
Inst Owner ChangeN/A
Ins Owners4.08%
Ins Owner ChangeN/A
Market Cap725.34M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts52.73
Price Target32.54 (54.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-6.02%
PT rev (3m)-15.6%
EPS NQ rev (1m)-94.61%
EPS NQ rev (3m)-316.84%
EPS NY rev (1m)0.79%
EPS NY rev (3m)-30.11%
Revenue NQ rev (1m)0.66%
Revenue NQ rev (3m)1.29%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)-0.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.69 | ||
| Fwd PE | 8.3 | ||
| P/S | 0.32 | ||
| P/FCF | N/A | ||
| P/OCF | 2.86 | ||
| P/B | 0.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.64 |
EPS(TTM)3.69
EY17.57%
EPS(NY)2.53
Fwd EY12.05%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY34.97%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.0494 (176.43%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.9 |
F-Score4
WACC7.49%
ROIC/WACC0.37
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-53.76%
EPS Next 2Y-26.46%
EPS Next 3Y-9.08%
EPS Next 5Y3.46%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year12.78%
Revenue Next 2Y7.56%
Revenue Next 3Y6.88%
Revenue Next 5Y6.99%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year81.16%
EBIT Next 3Y29.65%
EBIT Next 5Y20.08%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status for GXI stock?
ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for GERRESHEIMER AG?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for GXI stock?
The Price/Earnings (PE) ratio for GERRESHEIMER AG (GXI.DE) is 5.69 and the Price/Book (PB) ratio is 0.52.
How financially healthy is GERRESHEIMER AG?
The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.